Interview with Dr. Jeremy Greene on a Maryland law that prohibits price gouging on older essential drugs. (13:00)Download A new state law authorizes Maryland’s attorney general to prosecute firms that engage in price increases in noncompetitive off-patent–drug markets that are dramatic enough to “shock the conscience” of any reasonable consumer.
No takes yet. Share an insight, caveat, or question.
Greene et al. (2017) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: